BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30171323)

  • 1. Multimodal Interventional Treatment and Outcomes for Unruptured Arteriovenous Malformations.
    Maruyama D; Satow T; Kataoka H; Mori H; Hamano E; Orita Y; Eguchi S; Takahashi JC
    Acta Neurochir Suppl; 2018; 129():115-120. PubMed ID: 30171323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unruptured Brain Arteriovenous Malformations: Primary ONYX Embolization in ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Patients.
    Singfer U; Hemelsoet D; Vanlangenhove P; Martens F; Verbeke L; Van Roost D; Defreyne L
    Stroke; 2017 Dec; 48(12):3393-3396. PubMed ID: 29114088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution.
    Rutledge WC; Abla AA; Nelson J; Halbach VV; Kim H; Lawton MT
    Neurosurg Focus; 2014 Sep; 37(3):E8. PubMed ID: 25175446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Outcomes of A Randomized Trial of Unruptured Brain Arteriovenous Malformation-Eligible Unruptured Brain Arteriovenous Malformation Patients.
    Lang M; Moore NZ; Rasmussen PA; Bain MD
    Neurosurgery; 2018 Sep; 83(3):548-555. PubMed ID: 29040773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Unruptured Brain Arteriovenous Malformations: A Single-Center Experience of 86 Patients and a Critique of the A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) Trial.
    Link TW; Winston G; Schwarz JT; Lin N; Patsalides A; Gobin P; Pannullo S; Stieg PE; Knopman J
    World Neurosurg; 2018 Dec; 120():e1156-e1162. PubMed ID: 30218805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes of unruptured arteriovenous malformations with a subgroup analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-eligible patients.
    Nerva JD; Mantovani A; Barber J; Kim LJ; Rockhill JK; Hallam DK; Ghodke BV; Sekhar LN
    Neurosurgery; 2015 May; 76(5):563-70; discussion570; quiz 570. PubMed ID: 25635891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Radiosurgery for ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations)-Eligible Spetzler-Martin Grade I and II Arteriovenous Malformations: A Multicenter Study.
    Ding D; Starke RM; Kano H; Mathieu D; Huang PP; Kondziolka D; Feliciano C; Rodriguez-Mercado R; Almodovar L; Grills IS; Silva D; Abbassy M; Missios S; Barnett GH; Lunsford LD; Sheehan JP
    World Neurosurg; 2017 Jun; 102():507-517. PubMed ID: 28344176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of microsurgical excision of unruptured brain arteriovenous malformations in ARUBA-eligible patients.
    Javadpour M; Al-Mahfoudh R; Mitchell PS; Kirollos R
    Br J Neurosurg; 2016 Dec; 30(6):619-622. PubMed ID: 27172987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current surgical results with low-grade brain arteriovenous malformations.
    Potts MB; Lau D; Abla AA; Kim H; Young WL; Lawton MT;
    J Neurosurg; 2015 Apr; 122(4):912-20. PubMed ID: 25658789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tailored multimodal treatment for unruptured brain arteriovenous malformation: comparison with a randomized trial of unruptured brain arteriovenous malformations.
    Ikedo T; Yamamoto EH; Mori H; Niwa A; Ozaki S; Kushi Y; Shimonaga K; Hamano E; Yamada K; Imamura H; Iihara K; Kataoka H
    Acta Neurochir (Wien); 2023 Dec; 165(12):3779-3785. PubMed ID: 37779178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International multicenter cohort study of pediatric brain arteriovenous malformations. Part 2: Outcomes after stereotactic radiosurgery.
    Starke RM; Ding D; Kano H; Mathieu D; Huang PP; Feliciano C; Rodriguez-Mercado R; Almodovar L; Grills IS; Silva D; Abbassy M; Missios S; Kondziolka D; Barnett GH; Dade Lunsford L; Sheehan JP
    J Neurosurg Pediatr; 2017 Feb; 19(2):136-148. PubMed ID: 27911249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Outcomes of Endovascular Embolization Only in Patients with Unruptured Brain Arteriovenous Malformations: A Subgroup Analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations).
    Qureshi AI; Saeed O; Sahito S; Lobanova I; Liaqat J; Siddiq F; Gomez CR
    AJNR Am J Neuroradiol; 2020 Apr; 41(4):676-680. PubMed ID: 32115419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
    Mohr JP; Overbey JR; Hartmann A; Kummer RV; Al-Shahi Salman R; Kim H; van der Worp HB; Parides MK; Stefani MA; Houdart E; Libman R; Pile-Spellman J; Harkness K; Cordonnier C; Moquete E; Biondi A; Klijn CJM; Stapf C; Moskowitz AJ;
    Lancet Neurol; 2020 Jul; 19(7):573-581. PubMed ID: 32562682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.
    Mohr JP; Parides MK; Stapf C; Moquete E; Moy CS; Overbey JR; Al-Shahi Salman R; Vicaut E; Young WL; Houdart E; Cordonnier C; Stefani MA; Hartmann A; von Kummer R; Biondi A; Berkefeld J; Klijn CJ; Harkness K; Libman R; Barreau X; Moskowitz AJ;
    Lancet; 2014 Feb; 383(9917):614-21. PubMed ID: 24268105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality Management of Spetzler-Martin Grade 3 Brain Arteriovenous Malformations with Subgroup Analysis.
    Abecassis IJ; Nerva JD; Feroze A; Barber J; Ghodke BV; Kim LJ; Sekhar LN
    World Neurosurg; 2017 Jun; 102():263-274. PubMed ID: 28323192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ARUBA trial on trends and outcomes in symptomatic non-ruptured brain AVMs: A national sample analysis.
    Patel SD; Saber H; Desai N; Otite FO; Kaneko N; Mehta TV; Hinman J; Hassan AE; Jadhav A; Liebeskind DS; Saver JL
    J Stroke Cerebrovasc Dis; 2022 Dec; 31(12):106807. PubMed ID: 36272182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates in arteriovenous malformation management: the post-ARUBA era.
    Feghali J; Huang J
    Stroke Vasc Neurol; 2020; 5(1):34-39. PubMed ID: 32411406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intervention for A randomized trial of unruptured brain arteriovenous malformations (ARUBA) - Eligible patients: An evidence-based review.
    Hong CS; Peterson EC; Ding D; Sur S; Hasan D; Dumont AS; Chalouhi N; Jabbour P; Starke RM
    Clin Neurol Neurosurg; 2016 Nov; 150():133-138. PubMed ID: 27656780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Unruptured Low-Grade Brain Arteriovenous Malformations Using TOBAS (Treatment of Brain Arteriovenous Malformations Study) Criteria.
    Dumot C; Picart T; Eker O; Guyotat J; Berhouma M; Pelissou-Guyotat I
    World Neurosurg; 2022 Nov; 167():e1050-e1061. PubMed ID: 36089272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Outcomes of Patients With Giant Intracranial Arteriovenous Malformations.
    Yang W; Wei Z; Wang JY; Hung AL; Caplan JM; Braileanu M; Colby GP; Coon AL; Tamargo RJ; Huang J
    Neurosurgery; 2016 Jul; 79(1):116-24. PubMed ID: 26695091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.